December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Impressive progress in prostate adeno/NEPC driven in large part by Misha Beltran
Oct 13, 2024, 05:19

Impressive progress in prostate adeno/NEPC driven in large part by Misha Beltran

Toni Choueiri shared a post on X:

What can Misha Beltran not do?

Impressive progress in prostate adeno/NEPC driven in large part by her tenacity and leadership !

A gift having her part of the Dana-Farber Lank Center for Genitourinary Oncology! “

Impressive progress in prostate adeno/NEPC driven in large part by Misha Beltran

Toni Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber Toni Choueiriand past President of the Medical Staff at DFCI (2016-2018).

He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.

Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.